|Daily Range||$24.80 - $25.85|
|52-Week Range||$13.88 - $28.48|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||458,485|
|Current FY EPS||$1.19|
Emergent BioSolutions (EBS) Description
Emergent BioSolutions makes the only FDA-approved anthrax vaccine. Website: http://www.emergentbiosolutions.com/
Gilead Sciences is widely known for its HIV drug portfolio and for its high-profile hep-C drug sofosbuvir. But it also has a potential winner with idelalisib, a blood cancer drug with a promising future.